BT8009 drug page Clinical trials

Trials with BT8009

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
0Recruiting
6Countries
329Planned patients

Showing 1–1 of 1

Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
Ongoing, not recruiting Phase 1 329 patients NCT04561362

This study is a Phase I/II, multicenter, first-in-human, open-label dose-escalation study of BT8009 given as a single agent and in combination with pembrolizumab in participants with advanced solid tumors associated with Nectin-4 expressio…

United States, Canada, France, Italy and 2 more Jul 2020 – Dec 2026 Interventional
Combined with: Pembrolizumab